Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Finished Goods (2016 - 2025)

Phibro Animal Health has reported Finished Goods over the past 13 years, most recently at $309.7 million for Q4 2025.

  • Quarterly results put Finished Goods at $309.7 million for Q4 2025, up 21.43% from a year ago — trailing twelve months through Dec 2025 was $309.7 million (up 21.43% YoY), and the annual figure for FY2025 was $253.8 million, up 49.69%.
  • Finished Goods for Q4 2025 was $309.7 million at Phibro Animal Health, up from $279.6 million in the prior quarter.
  • Over the last five years, Finished Goods for PAHC hit a ceiling of $309.7 million in Q4 2025 and a floor of $133.2 million in Q1 2021.
  • Median Finished Goods over the past 5 years was $170.8 million (2023), compared with a mean of $190.6 million.
  • Biggest five-year swings in Finished Goods: decreased 3.0% in 2024 and later surged 63.76% in 2025.
  • Phibro Animal Health's Finished Goods stood at $147.6 million in 2021, then rose by 16.81% to $172.4 million in 2022, then grew by 7.05% to $184.6 million in 2023, then soared by 38.16% to $255.0 million in 2024, then increased by 21.43% to $309.7 million in 2025.
  • The last three reported values for Finished Goods were $309.7 million (Q4 2025), $279.6 million (Q3 2025), and $253.8 million (Q2 2025) per Business Quant data.